<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9857">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05688748</url>
  </required_header>
  <id_info>
    <org_study_id>2022328-11112</org_study_id>
    <nct_id>NCT05688748</nct_id>
  </id_info>
  <brief_title>Effectiveness Evaluation of a Dengue Self-monitoring System</brief_title>
  <acronym>DeSMoS</acronym>
  <official_title>Effectiveness Evaluation of a Dengue Self-monitoring System (DeSMoS) to Reduce Treatment Delay in Malaysia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Malaya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Malaysia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Malaya</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this clinical trial is to compare the effectiveness of a dengue self-monitoring&#xD;
      system with standard care in reducing treatment delay among dengue patients receiving&#xD;
      outpatient care. The main question it aims to answer are:&#xD;
&#xD;
      â€¢ Is a dengue self-monitoring system effective in reducing treatment delay in dengue&#xD;
      patients? Participants will use the dengue monitoring system in addition to the standard care&#xD;
      they are receiving for outpatient follow up for dengue.&#xD;
&#xD;
      Researchers will compare them with dengue patients receiving the usual standard care to see&#xD;
      if the dengue monitoring system reduces delay in treatment seeking in patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dengue Self-Monitoring System (DeSMoS) was developed to guide patients about warning signs&#xD;
      and advise them to visit a doctor appropriately before their scheduled follow up on the next&#xD;
      day, apart from motivating them to comply to the daily follow up visits at the clinic. DeSMoS&#xD;
      is hypothesised to effectively reduce delay in treatment seeking in dengue patients.&#xD;
&#xD;
      The main aim of this system is to get dengue patients to key-in their symptoms regularly via&#xD;
      the app when they are at home. Reminders will appear on the phone to remind them to key in&#xD;
      the symptoms thrice daily.&#xD;
&#xD;
      The system is designed as a supportive tool for outpatient dengue management. It is not meant&#xD;
      to replace to usual standard care for dengue care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 20, 2023</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in treatment delay</measure>
    <time_frame>Up to two weeks</time_frame>
    <description>Proportion of patients with warning symptoms who return to see a doctor earlier than scheduled</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compliance to follow up</measure>
    <time_frame>Up to two weeks</time_frame>
    <description>Proportion of patients who are compliant of all follow up visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development of warning symptoms</measure>
    <time_frame>Up to two weeks</time_frame>
    <description>Proportion of patients who develop warning symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization</measure>
    <time_frame>Up to two weeks</time_frame>
    <description>Proportion of patients with warning symptoms who are admitted to hospital</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Dengue</condition>
  <arm_group>
    <arm_group_label>Dengue monitoring system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participants will be given access to download a dengue self-monitoring application and use the application at home to key in their symptoms, three times a day throughout their outpatient follow up for dengue.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will be managed as per usual outpatient care for dengue in the clinic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dengue self-monitoring system</intervention_name>
    <description>The system has a symptom monitoring algorithm whereby patient would be asked to report their symptoms thrice daily (9am, 2pm and 8pm). The algorithm is developed by the researchers which consist of primary care doctors, emergency physician and infectious disease specialists. If the patient reports warning symptoms (persistent vomiting, persistent diarrhoea, abdominal pain, bleeding, difficulty breathing, feel like fainting, difficulty carrying out usual activities, drowsiness, reduced urine output and reduced urine output), the system will advise patients to seek earlier medical care instead of waiting for the scheduled appointment the next day/other days.</description>
    <arm_group_label>Dengue monitoring system</arm_group_label>
    <other_name>DeSMoS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 years old and above&#xD;
&#xD;
          -  Newly diagnosed with dengue fever&#xD;
&#xD;
          -  Have a smartphone&#xD;
&#xD;
          -  Receiving outpatient follow up for dengue&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hearing and speech impairment&#xD;
&#xD;
          -  Cognitive impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Leik Ng</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Malaya</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Santralega Lingam</last_name>
    <phone>+6017-2254820</phone>
    <email>santralega@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinik Kesihatan Seksyen 7 Shah Alam</name>
      <address>
        <city>Shah Alam</city>
        <state>Selangor</state>
        <zip>40000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Santralega Lingam</last_name>
      <phone>+6017-2254820</phone>
      <email>santralega@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Wei Leik Ng</last_name>
      <phone>+603-79492306</phone>
      <email>wlng@ummc.edu.my</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <results_reference>
    <citation>Leo YS, Gan VC, Ng EL, Hao Y, Ng LC, Pok KY, Dimatatac F, Go CJ, Lye DC. Utility of warning signs in guiding admission and predicting severe disease in adult dengue. BMC Infect Dis. 2013 Oct 24;13:498. doi: 10.1186/1471-2334-13-498.</citation>
    <PMID>24152678</PMID>
  </results_reference>
  <results_reference>
    <citation>Herbuela VRDM, Karita T, Francisco ME, Watanabe K. An Integrated mHealth App for Dengue Reporting and Mapping, Health Communication, and Behavior Modification: Development and Assessment of Mozzify. JMIR Form Res. 2020 Jan 8;4(1):e16424. doi: 10.2196/16424.</citation>
    <PMID>31913128</PMID>
  </results_reference>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>January 5, 2023</study_first_submitted>
  <study_first_submitted_qc>January 17, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2023</study_first_posted>
  <last_update_submitted>March 23, 2023</last_update_submitted>
  <last_update_submitted_qc>March 23, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dengue</keyword>
  <keyword>outpatient care</keyword>
  <keyword>self-monitoring system</keyword>
  <keyword>treatment delay</keyword>
  <keyword>warning symptoms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dengue</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

